acebutolol has been researched along with penbutolol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Povetkin, SV | 1 |
| Pala, AM; Ricciardelli, D; Sanna, A; Vinattieri, MA | 1 |
| Clucas, A; Miller, N | 1 |
| Rosselot, E | 1 |
| Hagel, F; Ulm, K | 1 |
| Ahuja, RC; Hussain, M; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH; Verma, SP | 1 |
| Müller, FO; Steyn, JM | 1 |
| Hagel, F | 1 |
| Bredikhin, VT; Dementéva, NG; Filippenko, NG; Povetkin, SV; Smirnova, II | 1 |
2 review(s) available for acebutolol and penbutolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Effects of acebutolol on the serum lipid profile.
Topics: Acebutolol; Cholesterol; Humans; Lipoproteins; Penbutolol; Pindolol; Propranolol; Triglycerides | 1988 |
6 trial(s) available for acebutolol and penbutolol
| Article | Year |
|---|---|
[Comparative effectiveness of various beta adrenergic blockaders in hypertension].
Topics: Acebutolol; Adult; Blood Pressure; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propranolol | 1991 |
[The effect of beta blockers on the QT interval: the possible role of mechanisms other than beta block].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Electrocardiography; Female; Humans; Hypertension; Middle Aged; Penbutolol; Randomized Controlled Trials as Topic; Regression Analysis | 1989 |
[Effect of 8 week beta blocker therapy on parameters of circulation and lipid metabolism].
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Circulation; Humans; Hypertension; Lipid Metabolism; Penbutolol | 1983 |
Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
Topics: Acebutolol; Adult; Angina Pectoris; Clinical Trials as Topic; Dose-Response Relationship, Drug; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Penbutolol; Propanolamines; Propranolol | 1984 |
[Comparative studies with beta blockers in hypertensive patients in ambulatory care].
Topics: Acebutolol; Adolescent; Adult; Ambulatory Care; Female; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged; Penbutolol; Propanolamines | 1982 |
[Pharmaco -- genetic approach to the improvement of beta-adrenoblocker therapy in the treatment of hypertension].
Topics: Acebutolol; Adult; Blood Pressure; Humans; Hypertension; Lipid Peroxidation; Male; Middle Aged; Penbutolol; Propranolol; Regression Analysis | 1993 |
6 other study(ies) available for acebutolol and penbutolol
| Article | Year |
|---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
[Use of beta blockaders in arrhythmias and ischemic heart disease].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Catecholamines; Coronary Disease; Electrocardiography; Female; Heart Rate; Humans; Male; Penbutolol | 1982 |
Comparative effects of two commercially available blood collection tubes on plasma concentrations of drugs.
Topics: Acebutolol; Blood Specimen Collection; Carbamazepine; Diazepam; Digoxin; Ethosuximide; Humans; Nordazepam; Penbutolol; Pharmaceutical Preparations; Propranolol; Quinidine; Salicylates; Time Factors; Valproic Acid; Warfarin | 1980 |